New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.
| Image |  |
|---|---|
| Description | scientific article published on 24 January 2012 |
| Author/s |
author: Giovanni Scapagnini Michael Berk Zdeněk Fišar Miguel Medina Michael Maes Gabriel Nowak |
| Publication date | January 24, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |